Insiders / Bazemore Robert B
Bazemore Robert B
CIK 1620152personinsider
Companies
4
First seen
Jan 27, 2021
Last activity
Jun 18, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Epizyme, Inc. · EPZM | 322,626 | — |
| Ardelyx, Inc. · ARDX | 68,006 | — |
| Nuvation Bio Inc. · NUVB | 5,000 | — |
| Akari Therapeutics Plc · AKTX | — | — |
All securities held
12 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Akari Therapeutics Plc | Depositary shares | 44,642 |
| Ardelyx, Inc. | Common stock | 68,006 |
| Epizyme, Inc. | Common stock | 322,626 |
| Nuvation Bio Inc. | Class A common stock | 5,000 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Akari Therapeutics Plc | Options | 225,000 |
| Akari Therapeutics Plc | Class A options | 44,642 |
| Akari Therapeutics Plc | Class B options | 44,642 |
| Akari Therapeutics Plc | Warrants | 30,932 |
| Ardelyx, Inc. | Options | 39,715 |
| Epizyme, Inc. | Options | 417,443 |
| Nuvation Bio Inc. | Options | 123,397 |
Other
| Company | Security | Shares |
|---|---|---|
| Ardelyx, Inc. | Unclassified | 32,765 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 25, 2021 | Sell Open-market sale | EPZM Epizyme, Inc. Common Stock, par value $0.0001 | $81.1K | -10K -3.10% | 322,626 | low |
| Jan 25, 2021 | Sell Open-market sale | EPZM Epizyme, Inc. Common Stock, par value $0.0001 | $69.2K | -6K -2.39% | 248,367 | low |
| Mar 6, 2025 | Grant Grant or award | AKTX Akari Therapeutics Plc American Depositary Shares representing Ordinary Shares |